Citigroup’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-9,423
| Closed | -$44K | – | 7932 |
|
|
2019
Q1 | $44K | Buy |
9,423
+2,988
| +46% | +$14.1K | ﹤0.01% | 6448 |
|
|
2018
Q4 | $22K | Sell |
6,435
-2,901
| -31% | -$20.2K | ﹤0.01% | 6840 |
|
|
2018
Q3 | $94K | Buy |
9,336
+6,269
| +204% | +$50K | ﹤0.01% | 5974 |
|
|
2018
Q2 | $22K | Sell |
3,067
-2,144
| -41% | -$14.9K | ﹤0.01% | 6885 |
|
|
2018
Q1 | $32K | Sell |
5,211
-48
| -0.9% | -$396 | ﹤0.01% | 6475 |
|
|
2017
Q4 | $50K | Sell |
5,259
-8,510
| -62% | -$55.7K | ﹤0.01% | 6187 |
|
|
2017
Q3 | $123K | Buy |
13,769
+4,373
| +47% | +$45.1K | ﹤0.01% | 5404 |
|
|
2017
Q2 | $119K | Sell |
9,396
-171
| -2% | -$2.02K | ﹤0.01% | 5221 |
|
|
2017
Q1 | $100K | Sell |
9,567
-54,347
| -85% | -$579K | ﹤0.01% | 5217 |
|
|
2016
Q4 | $587K | Buy |
63,914
+32,964
| +107% | +$372K | ﹤0.01% | 4214 |
|
|
2016
Q3 | $365K | Buy |
30,950
+12,439
| +67% | +$189K | ﹤0.01% | 4182 |
|
|
2016
Q2 | $240K | Sell |
18,511
-4,309
| -19% | -$62.8K | ﹤0.01% | 4330 |
|
|
2016
Q1 | $365K | Buy |
22,820
+14,197
| +165% | +$270K | ﹤0.01% | 4484 |
|
|
2015
Q4 | $247K | Sell |
8,623
-21,822
| -72% | -$605K | ﹤0.01% | 4545 |
|
|
2015
Q3 | $866K | Buy |
30,445
+5,552
| +22% | +$204K | ﹤0.01% | 3228 |
|
|
2015
Q2 | $894K | Sell |
24,893
-385
| -2% | -$12K | ﹤0.01% | 3234 |
|
|
2015
Q1 | $735K | Sell |
25,278
-4,930
| -16% | -$130K | ﹤0.01% | 3368 |
|
|
2014
Q4 | $637K | Buy |
30,208
+11,556
| +62% | +$229K | ﹤0.01% | 3625 |
|
|
2014
Q3 | $362K | Buy |
18,652
+16,048
| +616% | +$252K | ﹤0.01% | 3779 |
|
|
2014
Q2 | $41K | Sell |
2,604
-4,558
| -64% | -$73.7K | ﹤0.01% | 5299 |
|
|
2014
Q1 | $148K | Sell |
7,162
-2,132
| -23% | -$42.3K | ﹤0.01% | 4632 |
|
|
2013
Q4 | $120K | Buy |
9,294
+9,270
| +38,625% | +$129K | ﹤0.01% | 5111 |
|
|
2013
Q3 | $0 | Buy |
+24
| New | +$197 | ﹤0.01% | 7093 |
|
Other funds holding INSY
WS
Citigroup's INSY Position: Q2 2019 in Review
Citigroup sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 9,423 shares — an estimated $44K sold.
Citigroup first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $894K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Citigroup reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Citigroup sold 9,423 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $44K.
- Citigroup first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
- Citigroup's Insys Therapeutics, Inc. position peaked at $894K in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.